Cooley advised Decagon, an innovator in conversational artificial intelligence agents for customer experience, on its $131 million Series C financing round, pushing its total funding to $231 million.
Cooley advised Decagon, an innovator in conversational artificial intelligence agents for customer experience, on its $131 million Series C financing round, pushing its total funding to $231 million.
Premier Partners Closes $15 Million Investment in Celltrio
June 17, 2025
Cooley advised Premier Partners on its $15 million investment in Celltrio, a pioneering life sciences company delivering advanced automation solutions for cell culturing and cell and gene therapy. Premier Partners is a growth equity investment firm managing $2.9 billion in assets, focusing on rapidly growing sectors, particularly within the healthcare industry. Partner Sale Kwon led the Cooley team.
L&F’s Strategic Investment in Mitra Chem to Advance US Battery Production
March 21, 2025
Cooley advised L&F Co., a leading South Korean electric vehicle (EV) battery materials supplier, on its $10 million strategic investment in US-based lithium-ion battery startup Mitra Chem. Partner Sale Kwon led the Cooley team that provided legal advice across due diligence, investment structuring and regulatory compliance. The investment supports L&F’s US expansion and plans for joint lithium iron phosphate (LFP) cathode material production by 2027.
Cooley advised Baseten, the top inference platform for artificial intelligence (AI)-native products, on its $75 million Series C financing, bringing its total funding to $135 million.
